Work

MA11.04 Updated Efficacy, Safety and Dosing Management of Poziotinib in Previously Treated EGFR and HER2 Exon 20 NSCLC Patients

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.249

Authors: R. Cornelissen, M.C. Garassino, X. Le, J. Clarke, N. Tchekmedyian, J. Goldman, F. Lebel, G. Bhat, M. Socinski

Institutions: Erasmus MC, Fondazione IRCCS Istituto Nazionale dei Tumori, The University of Texas MD Anderson Cancer Center, Duke Cancer Institute, University of California, Los Angeles, Spectrum Pharmaceuticals (United States), AdventHealth

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Memorial Sloan-Kettering Cancer Center, Merck KGaA, Institut National de la Santé et de la Recherche Médicale, Yonsei University, Sungkyunkwan University, Università degli Studi di Padova, National Yang-Ming University, National Taiwan University Hospital, National Taiwan University, Centre Hospitalier Universitaire de Toulouse, Universitätsspital Zürich, Istituto Oncologico Veneto, Deutsches Zentrum für Lungenforschung, Taipei Veterans General Hospital, Samsung, University of Texas MD Anderson Cancer Center, Yonsei University College of Medicine

OpenAlex ID: W3138654081

Cites:

Cited by: 8

Related to: 10